Millipore And Gen-Probe Launch First Real-Time Test For Detecting Microbial Contamination In Biopharmaceutical Applications
Jan 12th 2008Drug InformationPharma Industry
Millipore Corporation (NYSE:MIL) and Gen-Probe (NASDAQ:GPRO) announced the launch of the first product from their ground-breaking collaboration to create faster, sensitive, more robust tests for detecting contaminants in pharmaceutical and biotechnology manufacturing processes. The MilliPROBE system is the first solution of its kind for biopharmaceutical manufacturing.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
